Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

NCT00904735 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: hydroxyurea
DRUG: imatinib mesylate

Sponsor

Istituto Scientifico H. San Raffaele